Jennifer Bournique

Jennifer Bournique is an experienced professional in the field of clinical research and risk management, currently serving as the VP of Consulting Services at CluePoints since January 2022. Previous roles include Associate Director of Study Lead Country Operations at Alexion Pharmaceuticals and Associate Director of Risk Management & Central Monitoring at The Janssen Pharmaceutical Companies of Johnson & Johnson. Jennifer has a robust background in Analytical Risk-Based Monitoring (ARBM), having managed and executed ARBM processes across various companies, including DOCS Global and Roche Diagnostics, where responsibilities included training monitoring staff and ensuring compliance with regulations. Jennifer holds a Bachelor of Science degree in Chemistry from Indiana State University.